NCT00655239 Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis Status COMPLETED Phase NA
NCT00654706 Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT00654576 Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia Status COMPLETED Phase PHASE4
NCT00653406 A Pharmacokinetic and Safety Study of Risperidone Long Acting Injectable in Schizophrenic Patients Status COMPLETED Phase PHASE1/PHASE2
NCT00650793 A 52-week, Open-label Extension Study Following a 6-week, Double-blind, Placebo- and Active- Controlled Study (R076477-SCH-303) to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophrenia Status COMPLETED Phase PHASE3
NCT00650611 A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders Status COMPLETED Phase PHASE2
NCT00650429 A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective Disorder Status COMPLETED Phase PHASE4
NCT00649844 A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs Status COMPLETED Phase PHASE3
NCT00649064 A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic Drugs Status COMPLETED Phase PHASE4
NCT00646581 Effect of Single Dose Intranasal Insulin On Cognitive Function Status COMPLETED Phase PHASE4
NCT00646256 Cognitive Determinants of Psychoeducation and Information in Psychoses Status UNKNOWN Phase NA
NCT00645944 Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia Status COMPLETED Phase NA
NCT00645580 Genetic Expression in Schizophrenics Treated With SSRI Augmentation: Relationship to Clinical and Cognitive Function Status UNKNOWN Phase NA
NCT00645515 A Study Comparing the Safety and Efficacy of Ziprasidone and Risperidone for the Treatment of Chronic Schizophrenia Status TERMINATED Phase PHASE3
NCT00645502 Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet. Status COMPLETED Phase PHASE1
NCT00645372 A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese Patients Status COMPLETED Phase PHASE3
NCT00645307 A 52 Week Open Label Extension Trial Following the Recurrence Prevention Study R076477-SCH-301 to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophrenia. Status COMPLETED Phase PHASE3
NCT00645229 A Study of the Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder Status TERMINATED Phase PHASE3
NCT00645099 A 6 Month Study to Compare the Metabolic Effects of Paliperidone ER and Olanzapine in Patients With Schizophrenia Status COMPLETED Phase PHASE3